ClinConnect ClinConnect Logo
Search / Trial NCT06310434

Analysis of COMPASsion and Humanisation of Adolescents Facing the End-of-life Processes.

Launched by INSTITUTO DE SALUD CARLOS III · Mar 7, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Compassion Death Anxiety Multicenter Study Adolescent Qualitative Research

ClinConnect Summary

This clinical trial, called "Analysis of COMPASsion and Humanisation of Adolescents Facing the End-of-life Processes," is studying how to improve compassion in young people aged 12 to 23 who are facing the topic of death and dying. The researchers want to understand how raising awareness and encouraging discussions about compassion can help teenagers develop a better understanding of the suffering of others, especially in end-of-life situations. They will work with students from both public secondary schools and universities across six provinces in Spain, involving families and teachers to support meaningful changes.

To participate, students must be enrolled in the same health area schools or universities and be between 12 to 23 years old. The trial will begin with an anonymous survey to assess how compassionate the adolescents feel and their attitudes towards death. After that, participants will engage in various activities, like discussions and creative projects, to explore these topics further. The goal is to empower young people to support each other and their communities during difficult times. By the end of the study, researchers will evaluate the impact of these activities on the participants' compassion levels and gather feedback to understand their experiences better. This project aims to enhance the quality of life for adolescents and contribute to a more compassionate society.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • University and high schools that belong to the same "Health Area"
  • Students enrolled in public secondary schools (12-17 years old) and in different undergraduate studies in a public University (18-23 years old) during the development of the project
  • Parents, mothers, or legal tutors of minors with communication skills to participate in a group
  • Exclusion Criteria:
  • Students who need curricular adaptation
  • Health science studies at the University

About Instituto De Salud Carlos Iii

Instituto de Salud Carlos III (ISCIII) is a prominent Spanish public research institution dedicated to advancing health through scientific investigation and innovation. As a key player in the national health system, ISCIII focuses on biomedical research, epidemiology, and public health, aiming to improve health outcomes and inform health policy. The institute fosters collaboration among researchers, healthcare professionals, and stakeholders, and it plays a pivotal role in funding and supporting clinical trials that contribute to the understanding and treatment of various diseases. Through its commitment to excellence and impact in health research, ISCIII is instrumental in shaping the future of healthcare in Spain and beyond.

Locations

Murcia, Mu, Spain

Patients applied

0 patients applied

Trial Officials

Eva Abad-Corpa, PhD

Principal Investigator

Instituto Murciano de Investigación Biosanitaria

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported